CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

vsl #3

Cell therapyexperimental

Clinical trial activity

44 trials · 66 clinical orgs · 0 marketing orgs

Phase 1
4
Phase 2
14
Phase 3
10
Phase 4
7

Earliest trial started Dec 1, 2003 (NCT00175292)

Timeline

2000s

  1. Jan 1, 2003

    Earliest Phase 3 Sponsor(trial)

  2. Jan 1, 2004

    Earliest Phase 1 Sponsor(trial)

  3. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • vsl #3
  • vsl#3

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06609447Phase 4Sep 21, 2024Zhejiang University
NCT06508034N/AJul 31, 2024Mayo Clinic
NCT05501470Phase 2Dec 31, 2022Aga Khan University, Bill and Melinda Gates Foundation, Institut Pasteur, International Center for Diarrheal Disease Research, University of Zambia
NCT05608928Phase 2Dec 1, 2022Aga Khan University, Bill and Melinda Gates Foundation, Institut Pasteur, International Center for Diarrheal Disease Research, Tropical Gastroenterology & Nutrition Group (TROPGAN)
NCT05874089N/ANov 3, 2022A.O. Ospedale Maggiore di Lodi
NCT03586622N/ASep 1, 2018Calpro AS, Colitis-Crohn Foreningen, Ferring, Genetic Analysis, North Zealands University Hospital, Statens Serum Institut, University of Copenhagen
NCT03682094Early Phase 1 (Phase 1)Aug 13, 2018University of Wisconsin
NCT04256785N/AMay 11, 2018Ferring, University of Granada, VSL Pharmaceuticals
NCT03423589N/AApr 23, 2018Medical College of Wisconsin
NCT03327051Phase 4Nov 30, 2017Stanford University
NCT03165747Phase 2Jul 5, 2017Emory University
NCT03052179N/AMay 1, 2017University of London
NCT03092427N/AMay 1, 2017University of Paris
NCT03415711N/AApr 28, 2017Universita' Cattolica del Sacro Cuore, VSL Pharmaceuticals
NCT02545413Phase 3May 1, 2016Government Medical College, India, Government Medical College, Kozhikide, Kerala, India, Next Gen Pharma India Pvt. Ltd.
NCT03115385N/AMay 30, 2015University of Southern California
NCT03533621N/ASep 4, 2014University of California, San Diego
NCT01877967N/AMay 1, 2013Trinity College Dublin, VSL Pharmaceuticals
NCT01798329Phase 3Mar 1, 2013University of Brescia, University of Milan, University of Padua
NCT01632462Phase 4Sep 1, 2012University of Naples Frederico II
Showing 20 of 44 trials
Page 1 / 3

Organizations

Research & Development (66)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
VSL PharmaceuticalsFor profit8342004
FerringFor profit3022010
Aga Khan UniversityAcademic/Hospital2012022
All India Institute of Medical SciencesAcademic/Hospital2112007
Bill and Melinda Gates FoundationAcademic/Hospital2012022
CD Pharma India Pvt. Ltd.For profit2212009
Hebrew UniversityAcademic/Hospital2222004
Institut PasteurAcademic/Hospital2112022
International Center for Diarrheal Disease ResearchAcademic/Hospital2012022
University of LondonAcademic/Hospital2222007
University of WisconsinAcademic/Hospital2222008
A.O. Ospedale Maggiore di LodiAcademic/Hospital1112022
Asian Institute of GastroenterologyAcademic/Hospital1112012
Calpro ASFor profit1012018
Canadian Institutes of Health Research (CIHR)Academic/Hospital1012003
Catholic University of Sacred Heart, RomeAcademic/Hospital1112012
Chinese University of Hong KongAcademic/Hospital1112010
Colitis-Crohn ForeningenAcademic/Hospital1012018
Dutch Cancer SocietyAcademic/Hospital1012006
Emory UniversityAcademic/Hospital1112017
66 organizations
Page 1 / 4